APA (7th ed.) Citation

B, M., I, F., N, C., J, B., E, A., R, C., . . . C, D. (2025). SIRE: Short interval in real life Does intensive anti-VEGF treatment in the first year predict subsequent treatment burden in exudative age-related macular degeneration? Eye (London, England), 39(9), 1797. https://doi.org/10.1038/s41433-025-03734-0

Chicago Style (17th ed.) Citation

B, Matagrin, Fenniri I, Chirpaz N, Billant J, Agard E, Chudzinski R, Burillon C, and Dot C. "SIRE: Short Interval in Real Life Does Intensive Anti-VEGF Treatment in the First Year Predict Subsequent Treatment Burden in Exudative Age-related Macular Degeneration?" Eye (London, England) 39, no. 9 (2025): 1797. https://doi.org/10.1038/s41433-025-03734-0.

MLA (9th ed.) Citation

B, Matagrin, et al. "SIRE: Short Interval in Real Life Does Intensive Anti-VEGF Treatment in the First Year Predict Subsequent Treatment Burden in Exudative Age-related Macular Degeneration?" Eye (London, England), vol. 39, no. 9, 2025, p. 1797, https://doi.org/10.1038/s41433-025-03734-0.